Skip to main content

BIO-PATH HOLDINGS INC

For the period ended Dec 12, 2024. Filed Oct 28, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Dec 12, 2024 · Filed Oct 28, 2024

BPTH$0.21-66.8%Stored close · as of Feb 18, 2025
See the whole filing, with its images and exhibits
Contents

Summary Compensation Table

The following table sets forth information with respect to the compensation of our sole NEO for the fiscal years ended December 31, 2023 and 2022.

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
Name and · ​ · ​ · ​ · ​ · ​ · Option · All Other · ​ · ​
Principal · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Awards · ​ · Compensation · ​ · ​ · ​
Position​Year​Salary ($)​Bonus ($)​($)(1)​($)​Total ($)
Peter H. Nielsen, CEO,2023​$575,000(2)$110,000(3)$130,880​$11,237(4)$827,117
CFO, President, Chairman, Director2022​$555,000​$150,000​$288,669​$17,678(5)$1,011,347
(1)The amounts reported in this column reflect the aggregate grant date fair value of equity awards granted during the year computed in accordance with FASB ASC Topic 718. See Note 9 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 for assumptions made by us in such valuation.
(2)Mr. Nielsen voluntarily reduced his base salary for 2023 to $400,000.
(3)Mr. Nielsen voluntarily elected to forego the entire $110,000 bonus.
(4)The amounts reported include Medicare premiums of $7,855, insurance copayments of $1,990 and certain other benefits including life insurance premiums paid by the Company for Mr. Nielsen.
(5)The amounts reported include Medicare premiums of $12,822, insurance copayments of $3,471 and certain other benefits including life insurance premiums paid by the Company for Mr. Nielsen.

Grants of Plan-Based Awards Table

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.